Analysis of Cell-Free DNA (as a genetic index for embryo quality)in an Iranian Women Undergoing IVF

Document Type : Original Article


1 Department of Biology, central Tehran branch, Islamic Azad University, Tehran, Iran

2 Infertility center of Tehran Yas hospital, medical school of Tehran University of medical science, Tehran, Iran

3 Kowsar Human Genetics Research Institute, Yas medical Genetics Lab, Tehran, Iran


1) Background: In vitro fertilization (IVF) is offered as a treatment for infertility in women.
. The Cell free DNA in plasma/follicles were suggested as a biomarker for embryo quality in
IVF. Higher the levels of Cell-free DNA indicate poorer embryo quality in the follicular fluid
during IVF. Therefore, this study was designed to examine the cell-free DNA (cfDNA) in
plasma and Fluid-follicle of women undergoing IVF-embryo transfer. 2) Methods: The study
examined 100 women undergoing IVF treatment in an IVF unit in Yas Hospital of Tehran
University of Medical Sciences in Tehran-Iran. Cell-free DNA was extracted from plasma
and follicular fluid of patients using the NucleoSpin® Extraction Kit. The total cfDNA was
examined by qPCR for ALBUMIN and GAPDH genes. 3) Results: we did not find a
statistically significant association among the variables such as CT-plasma, CT-follicular
fluid, delta-CT and average of these data between two groups (including patients who had a
successful IVF cycle and those who had a failed IVF cycle). 4) Conclusion: Plasma and
follicular fluid cfDNA may reflect the presence of factors which interfere with embryo
implantation. Further research is required to determine the usefulness of cfDNA as a
biomarker of IVF outcome and to examine the underlying pathologies as potential sources
for increased plasma/follicular fluid cfDNA concentrations.


Arnalich, F., et al. (2010). Association of cell-free plasma DNA with perioperative mortality in patients with suspected acute mesenteric ischemia. Clinica Chimica Acta. 411(17-18), 1269-1274.
Aydiner, F., et al. (2010). Perspectives on emerging biomarkers for non-invasive assessment of embryo viability in assisted reproduction. Current molecular medicine. 10(2), 206-215.
Borowiecka, M., et al. (2012). Oxidative stress markers in follicular fluid of women undergoing in vitro fertilization and embryo transfer. Systems biology in reproductive medicine. 58(6), 301-305.
Broekmans, F. J., et al. (2014). Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol. Human Reproduction. 29(8), 1688-1697.
Czamanski-Cohen, J., et al. (2013). Increased plasma cell-free DNA is associated with low pregnancy rates among women undergoing IVF–embryo transfer. Reproductive biomedicine online. 26(1), 36-41.
Díaz-Fontdevila, M., et al. (2009). Cumulus cell apoptosis changes with exposure to spermatozoa and pathologies involved in infertility. Fertility and sterility. 91(5), 2061-2068.
Duvvuri, B. and C. Lood (2019). Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases. Frontiers in immunology 10.
Fettke, H., et al. (2019). Cell-free DNA in cancer: current insights. Cellular Oncology. 42(1), 13-28.
Guan, Y., et al. (2017). Cell-free DNA induced apoptosis of granulosa cells by oxidative stress. Clinica Chimica Acta. 473, 213-217.
Hart, E. A., et al. (2005). Luteal phase serum cell-free DNA as a marker of failed pregnancy after assisted reproductive technology. Journal of assisted reproduction and genetics. 22(5), 213-217.
Jahr, S., et al. (2001). DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer research. 61(4), 1659-1665.
Lédée, N., et al. (2012). Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Human Reproduction. 28(2), 406-413.
Liu, J. and Y. Li (2010). Effect of oxidative stress and apoptosis in granulosa cells on the outcome of IVF-ET. Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Medical sciences. 35(9), 990-994.
Mandel, P. (1948). Les acides nucleiques du plasma sanguin chez 1 homme. CR Seances Soc Biol Fil. 142, 241-243.
Ossandon, M. R., et al. (2018). Circulating tumor DNA assays in clinical cancer research. JNCI: Journal of the National Cancer Institute. 110(9), 929-934.
Rafaeli-Yehudai, T., et al. (2018). Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation. PloS one. 13(7), e0200360.
Rodgers, R. J. and H. F. Irving-Rodgers (2010). Formation of the ovarian follicular antrum and follicular fluid. Biology of reproduction. 82(6), 1021-1029.
Rule, K., et al. (2018). Relationship between blastocoel cell-free DNA and day-5 blastocyst morphology. Journal of assisted reproduction and genetics. 35(8), 1497-1501.
Scalici, E., et al. (2014). Cell-free DNA in human follicular fluid as a biomarker of embryo quality. Human Reproduction. 29(12), 2661-2669.
Stokowski, R., et al. (2015). Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenatal diagnosis. 35(12),1243-1246.
Swarup, V. and M. Rajeswari (2007). Circulating (cell‐free) nucleic acids–A promising, non‐invasive tool for early detection of several human diseases. FEBS letters. 581(5), 795-799.
Umetani, N., et al. (2006). Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clinical chemistry. 52(6), 1062-1069.
Volume 1, Issue 2
April 2019
Pages 25-30
  • Receive Date: 08 June 2019
  • Revise Date: 15 October 2019
  • Accept Date: 28 March 2020
  • First Publish Date: 28 March 2020